- Graduate School
- Boston University School of Medicine (2009)
- Medical School
- Drexel University College of Medicine (2013)
- Tufts Medical Center (2016), Internal Medicine
- Montefiore Medical Center (2019), Hematology Oncology
- Treatment of Smoldering Myeloma: Problems With Study Design as well as Biological and Clinical Implications.
- Biran N, Vesole DH, Donato ML, Ip A, Kaur G, Goldberg S, Siegel DS, J Clin Oncol 2020 Apr 38 12 1367-1368
- Multiple myeloma in Hispanics- incidence, characteristics and survival, results of a discovery & validation cohort using real world and CONNECT data
- Kaur et al Clinical Lymphoma, Myeloma and Leukemia 2020
- Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies.
- Wang H, Kaur G, Sankin AI, Chen F, Guan F, Zang X, J Hematol Oncol 2019 06 12 1 59
- B7x- From Bench to Bedside
- Kaur G, Janakiram M ESMO Open 2019
- Outcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experience.
- Mato AR, Nabhan C, Barr PM, Ujjani CS, Hill BT, Lamanna N, Skarbnik AP, Howlett C, Pu JJ, Sehgal AR, Strelec LE, Vandegrift A, Fitzpatrick DM, Zent CS, Feldman T, Goy A, Claxton DF, Bachow SH, Kaur G, Svoboda J, Nasta SD, Porter D, Landsburg DJ, Schuster SJ, Cheson BD, Kiselev P, Evens AM, Blood 2016 11 128 18 2199-2205
- Translational research in pancreatic adenocarcinoma.
- Kaur G, Saif MW, JOP 2014 Mar 15 2 121-3